DENBRAYCE Trademark

Trademark Overview

On Tuesday, June 21, 2022, a trademark application was filed for DENBRAYCE with the United States Patent and Trademark Office. The USPTO has given the DENBRAYCE trademark a serial number of 79345335. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by MABXIENCE RESEARCH, S.L.. The DENBRAYCE trademark is filed in the Pharmaceutical Products category with the following description:

Oncology biosimilars, namely, biosimilar preparations for the treatment of cancer, and biosimilar preparations for the treatment of neoplasm metastasis
denbrayce

General Information

Serial Number79345335
Word MarkDENBRAYCE
Filing DateTuesday, June 21, 2022
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7265293
Registration DateTuesday, January 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements

Goods and ServicesOncology biosimilars, namely, biosimilar preparations for the treatment of cancer, and biosimilar preparations for the treatment of neoplasm metastasis
Translation of Words in MarkThe wording "DENBRAYCE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateSaturday, July 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMABXIENCE RESEARCH, S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES
Party NameMABXIENCE RESEARCH, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameMABXIENCE RESEARCH, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Wednesday, April 10, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 9, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Sunday, January 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 18, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, September 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 19, 2023REFUSAL PROCESSED BY IB
Tuesday, March 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 28, 2023REFUSAL PROCESSED BY MPU
Wednesday, February 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 31, 2023NON-FINAL ACTION WRITTEN
Thursday, January 26, 2023ASSIGNED TO EXAMINER
Wednesday, July 20, 2022APPLICATION FILING RECEIPT MAILED
Saturday, July 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 14, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

denbrayce treatment biosimilar preparations neoplasm metastasis cancer biosimilars oncology namely